AU Patent

AU2013232576B2 — Nitric oxide releasing pharmaceutical compositions

Assigned to Ligand Pharmaceuticals Inc · Expires 2016-09-01 · 10y expired

What this patent protects

The present invention generally relates to nitric oxide releasing pharmaceutical compositions and methods of using the same.

USPTO Abstract

The present invention generally relates to nitric oxide releasing pharmaceutical compositions and methods of using the same.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013232576B2
Jurisdiction
AU
Classification
—
Expires
2016-09-01
Drug substance claim
No
Drug product claim
No
Assignee
Ligand Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.